These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

657 related items for PubMed ID: 2023606

  • 1. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, Mankin HJ, Murray GJ, Parker RI, Argoff CE.
    N Engl J Med; 1991 May 23; 324(21):1464-70. PubMed ID: 2023606
    [Abstract] [Full Text] [Related]

  • 2. [Enzyme replacement therapy in type 1 Gaucher's disease].
    Aggio MC, Fernández V, Marcilese M.
    Medicina (B Aires); 1994 May 23; 54(2):140-4. PubMed ID: 7997130
    [Abstract] [Full Text] [Related]

  • 3. Alglucerase. A review of its therapeutic use in Gaucher's disease.
    Whittington R, Goa KL.
    Drugs; 1992 Jul 23; 44(1):72-93. PubMed ID: 1379912
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.
    Altarescu G, Schiffmann R, Parker CC, Moore DF, Kreps C, Brady RO, Barton NW.
    Blood Cells Mol Dis; 2000 Aug 23; 26(4):285-90. PubMed ID: 11042029
    [Abstract] [Full Text] [Related]

  • 5. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.
    Rosenthal DI, Doppelt SH, Mankin HJ, Dambrosia JM, Xavier RJ, McKusick KA, Rosen BR, Baker J, Niklason LT, Hill SC.
    Pediatrics; 1995 Oct 23; 96(4 Pt 1):629-37. PubMed ID: 7567322
    [Abstract] [Full Text] [Related]

  • 6. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W, Ali J, Abubakar S, Basar S, Murtaza G.
    J Ayub Med Coll Abbottabad; 2018 Oct 23; 30(3):479-481. PubMed ID: 30465391
    [Abstract] [Full Text] [Related]

  • 7. Taliglucerase alfa for the treatment of Gaucher's disease.
    Haddley K.
    Drugs Today (Barc); 2012 Aug 23; 48(8):525-32. PubMed ID: 22916340
    [Abstract] [Full Text] [Related]

  • 8. [Diagnosis and therapy of Gaucher disease].
    Ehlen C, Heintges T, Niederau C.
    Med Klin (Munich); 1995 May 15; 90(5):284-90. PubMed ID: 7791695
    [Abstract] [Full Text] [Related]

  • 9. Enzyme replacement and gene therapy for Gaucher's disease.
    Brady RO, Barton NW.
    Lipids; 1996 Mar 15; 31 Suppl():S137-9. PubMed ID: 8729108
    [Abstract] [Full Text] [Related]

  • 10. Gaucher's disease in Lithuania: its diagnosis and treatment.
    Kleinotienė G, Tylki-Szymanska A, Czartoryska B.
    Medicina (Kaunas); 2011 Mar 15; 47(7):405-11. PubMed ID: 22112991
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease.
    Altarescu G, Hill S, Wiggs E, Jeffries N, Kreps C, Parker CC, Brady RO, Barton NW, Schiffmann R.
    J Pediatr; 2001 Apr 15; 138(4):539-47. PubMed ID: 11295718
    [Abstract] [Full Text] [Related]

  • 12. Gaucher's disease: a review.
    Morales LE.
    Ann Pharmacother; 1996 Apr 15; 30(4):381-8. PubMed ID: 8729893
    [Abstract] [Full Text] [Related]

  • 13. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL, Zhang YH, Zang Y, Shi HP, Zhang WM, Hu YM.
    Zhonghua Er Ke Za Zhi; 2006 Sep 15; 44(9):653-6. PubMed ID: 17217655
    [Abstract] [Full Text] [Related]

  • 14. [Course of a case of Gaucher's disease type 1 treated over a year with glucocerebrosidase (Cérédase)].
    Belmatoug N, Azorin M, Huten D, de Villemeur TB, Carbon C.
    Rev Med Interne; 1993 Sep 15; 14(10):996. PubMed ID: 8009089
    [Abstract] [Full Text] [Related]

  • 15. [Enzyme replacement therapy: a new treatment concept in Gaucher disease].
    Beck M, Mengel E, Barone R.
    Wien Klin Wochenschr; 1997 Feb 14; 109(3):81-5. PubMed ID: 9139464
    [Abstract] [Full Text] [Related]

  • 16. A less costly regimen of alglucerase to treat Gaucher's disease.
    Figueroa ML, Rosenbloom BE, Kay AC, Garver P, Thurston DW, Koziol JA, Gelbart T, Beutler E.
    N Engl J Med; 1992 Dec 03; 327(23):1632-6. PubMed ID: 1435900
    [Abstract] [Full Text] [Related]

  • 17. Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase.
    Dale GL, Beutler E.
    Proc Natl Acad Sci U S A; 1976 Dec 03; 73(12):4672-4. PubMed ID: 1070017
    [Abstract] [Full Text] [Related]

  • 18. Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease.
    Schiffmann R, Heyes MP, Aerts JM, Dambrosia JM, Patterson MC, DeGraba T, Parker CC, Zirzow GC, Oliver K, Tedeschi G, Brady RO, Barton NW.
    Ann Neurol; 1997 Oct 03; 42(4):613-21. PubMed ID: 9382473
    [Abstract] [Full Text] [Related]

  • 19. [Gaucher's disease and enzyme replacement therapy].
    Cornu F.
    Ann Pharm Fr; 1998 Oct 03; 56(3):102-7. PubMed ID: 9770016
    [Abstract] [Full Text] [Related]

  • 20. Imiglucerase and its use for the treatment of Gaucher's disease.
    Weinreb NJ.
    Expert Opin Pharmacother; 2008 Aug 03; 9(11):1987-2000. PubMed ID: 18627336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.